{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:15Z","timestamp":1760059935005,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Coronary artery disease (CAD) constitutes a major contributor to morbidity, mortality and healthcare burden worldwide. Recent innovations in imaging modalities, pharmaceuticals and interventional techniques have revolutionized diagnostic and treatment options, necessitating the reevaluation of established drug protocols or the consideration of newer alternatives. The utilization of beta blockers (BBs) in the setting of acute myocardial infarction (AMI), shifting from the pre-reperfusion to the thrombolytic and finally the primary percutaneous coronary intervention (pPCI) era, has become increasingly more selective and contentious. Nonetheless, the extent of myocardial necrosis remains a key predictor of outcomes in this patient population, with large trials establishing the beneficial use of beta blockers. Computed tomography coronary angiography (CTCA) has emerged as a highly effective diagnostic tool for delineating the coronary anatomy and atheromatous plaque characteristics, with the added capability of MESH-3D model generation. Induction and preservation of a low heart rate (HR), regardless of the underlying sequence, is of critical importance for high-quality results. Landiolol is an intravenous beta blocker with an ultra-short duration of action (t1\/2 = 4 min) and remarkable \u03b21-receptor specificity (\u03b21\/\u03b22 = 255) and pharmacokinetics that support its potential for systematic integration into clinical practice. It has been increasingly recognized for its importance in both acute (primarily studied in STEMI and, to a lesser extent, NSTEMI pPCI) and chronic (mainly studied in elective PCI) CAD settings. Given the limited literature focusing specifically on landiolol, the aim of this narrative review is to examine its pharmacological properties and evaluate its current and future role in enhancing both diagnostic imaging quality and therapeutic outcomes in patients with CAD.<\/jats:p>","DOI":"10.3390\/jcm14155216","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:22:44Z","timestamp":1753280564000},"page":"5216","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Landiolol in Coronary Artery Disease: Insights into Acute Coronary Syndromes, Stable Coronary Artery Disease and Computed Tomography Coronary Angiography"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-5297","authenticated-orcid":false,"given":"Athina","family":"Nasoufidou","sequence":"first","affiliation":[{"name":"Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9409-388X","authenticated-orcid":false,"given":"Marios G.","family":"Bantidos","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-4696","authenticated-orcid":false,"given":"Panagiotis","family":"Stachteas","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios V.","family":"Moysidis","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0286-7762","authenticated-orcid":false,"given":"Andreas","family":"Mitsis","sequence":"additional","affiliation":[{"name":"Cardiology Department, Nicosia General Hospital, State Health Services Organization, Nicosia 2029, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-0134","authenticated-orcid":false,"given":"Barbara","family":"Fyntanidou","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kouskouras","sequence":"additional","affiliation":[{"name":"Department of Radiology, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-5942","authenticated-orcid":false,"given":"Efstratios","family":"Karagiannidis","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-5273","authenticated-orcid":false,"given":"Theodoros","family":"Karamitsos","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kassimis","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Fragakis","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0735-1097(24)04310-9","article-title":"Global Prevalence of Coronary Artery Disease: An Update from the Global Burden of Disease Study","volume":"83","author":"Stark","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2020.09.044","article-title":"Optimal Dose and Type of \u03b2-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention","volume":"137","author":"Park","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.jacc.2007.09.017","article-title":"Influence of Heart Rate on the Diagnostic Accuracy of Dual-Source Computed Tomography Coronary Angiography","volume":"50","author":"Ropers","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tsuchiya, H., and Mizogami, M. (2013). Characteristic interactivity of landiolol, an ultra-short-acting highly selective \u03b21-blocker, with biomimetic membranes: Comparisons with \u03b21-selective esmolol and non-selective propranolol and alprenolol. Front. Pharmacol., 4.","DOI":"10.3389\/fphar.2013.00150"},{"key":"ref_6","unstructured":"National Center for Biotechnology Information (2025, July 10). PubChem Compound Summary for CID 114905, Landiolol, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Landiolol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10557-023-07448-x","article-title":"Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials","volume":"38","author":"Sun","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"ehaa946.1576","DOI":"10.1093\/ehjci\/ehaa946.1576","article-title":"Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: A randomized, controlled study","volume":"41","author":"Miyamoto","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_9","first-page":"289","article-title":"Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patients with ST-segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention: A Randomized Study","volume":"75","author":"Miyamoto","year":"2021","journal-title":"Acta Med. Okayama"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jjcc.2012.06.010","article-title":"Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: Preliminary study","volume":"60","author":"Hoshi","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2016.07.076","article-title":"Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction","volume":"221","author":"Kiyokuni","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1253\/circj.CJ-11-0947","article-title":"Randomized study on the efficacy and safety of landiolol, an ultra-short-acting \u03b21-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"76","author":"Hanada","year":"2012","journal-title":"Circ. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"A102.E953","DOI":"10.1016\/S0735-1097(10)60954-0","article-title":"Feasibility of Continuous Intravenous Administration of Landiolol for Acute Myocardial Infarction: First Clinical Experience and Its Safe Directions for Use","volume":"55","author":"Higuchi","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","first-page":"469","article-title":"Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials","volume":"9","author":"Hoedemaker","year":"2020","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"A10337-A","DOI":"10.1161\/circ.132.suppl_3.10337","article-title":"Abstract 10337: Using Landiolol During Primary Percutaneous Coronary Intervention Attenuates Myocardial Reperfusion Injury in Patients With ST-segment Elevation Acute Myocardial Infarction","volume":"132","author":"Kiyokuni","year":"2015","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.cardfail.2010.07.101","article-title":"Low Dose Landiolol During Very Acute Phase of Acute Myocardial Infarction Improves Brain Natriuretic Peptide Level in the Chronic Phase","volume":"16","author":"Fujita","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.cardfail.2012.08.248","article-title":"Chronic Phase Effect of Landiolol about Left Ventricular Volume in Patients with Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention","volume":"18","author":"Fujita","year":"2012","journal-title":"J. Card. Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jacc.2008.07.048","article-title":"Radiation dose reduction and coronary assessability of prospective electrocardiogram-gated computed tomography coronary angiography: Comparison with retrospective electrocardiogram-gated helical scan","volume":"52","author":"Maruyama","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcct.2012.07.002","article-title":"Dual-energy CT and its potential use for quantitative myocardial CT perfusion","volume":"6","author":"So","year":"2012","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10554-013-0253-3","article-title":"A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting \u03b21-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease","volume":"29","author":"Jinzaki","year":"2013","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40261-013-0149-y","article-title":"A randomized, double-blind, placebo-controlled, phase III study of the short-acting \u03b21-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease","volume":"34","author":"Hirano","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12325-013-0053-0","article-title":"Dose-finding study of landiolol hydrochloride: A short-acting \u03b21-blocker for controlling heart rate during coronary computed-tomography angiography in Japan","volume":"30","author":"Hirano","year":"2013","journal-title":"Adv. Ther."},{"key":"ref_23","first-page":"1814","article-title":"Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: Initial experience","volume":"72","author":"Isobe","year":"2008","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_24","first-page":"1225","article-title":"Radiation-Dose-Lowering Effects of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography (DELIGHT)\u2014A Prospective Multicenter Study","volume":"80","author":"Kido","year":"2016","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2174\/1573405618666220518104929","article-title":"Effects of \u0392\u2013Blocker Administration on Cardiac Function: A Coronary Computed Tomography Angiography Study","volume":"18","author":"Kokubo","year":"2022","journal-title":"Curr. Med. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13244-024-01892-5","article-title":"Efficacy of bolus injections of landiolol hydrochloride as premedication in coronary artery CT angiography","volume":"16","author":"Barwig","year":"2025","journal-title":"Insights Imaging"},{"key":"ref_27","first-page":"146","article-title":"Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography","volume":"77","author":"Osawa","year":"2013","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/2193-1801-3-93","article-title":"A comparison of bolus injection of landiolol versus oral administration of propranolol before cardiac computed tomography","volume":"3","author":"Nakamura","year":"2014","journal-title":"SpringerPlus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14740\/jocmr3213w","article-title":"Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography","volume":"10","author":"Koyoshi","year":"2018","journal-title":"J. Clin. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"A123.E1150","DOI":"10.1016\/S0735-1097(10)61151-5","article-title":"Myocardial Protection by Intracoronary Administration of Short-Acting Beta-Blocker, Landiolol, During Elective Percutaneous Coronary Intervention","volume":"55","author":"Haengnam","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ijcard.2012.04.096","article-title":"Intracoronary followed by intravenous administration of the short-acting \u03b2-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention","volume":"167","author":"Park","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00380-020-01637-6","article-title":"Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention","volume":"35","author":"Kiyokuni","year":"2020","journal-title":"HearT Vessel."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1254\/jphs.11202FP","article-title":"Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts","volume":"118","author":"Shibata","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00540-009-0852-2","article-title":"Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts","volume":"24","author":"Yu","year":"2010","journal-title":"J. Anesth."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00540-007-0558-2","article-title":"Cardioprotective effect and mechanism of action of landiolol on the ischemic reperfused heart","volume":"21","author":"Kanaya","year":"2007","journal-title":"J. Anesth."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2009.07.013","article-title":"Efficacy of intracoronary administration of a short-acting \u03b2-blocker landiolol during reperfusion in pigs","volume":"146","author":"Park","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mitsis, A., Myrianthefs, M., Sokratous, S., Karmioti, G., Kyriakou, M., Drakomathioulakis, M., Tzikas, S., Kadoglou, N.P.E., Karagiannidis, E., and Nasoufidou, A. (2024). Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081670"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2217\/bmm-2023-0491","article-title":"Role of Inflammation Following An Acute Myocardial Infarction: Design of INFINITY","volume":"17","author":"Mitsis","year":"2023","journal-title":"Biomark. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nasoufidou, A., Papazoglou, A.S., Stachteas, P., Karagiannidis, E., Samaras, A., Alexiou, S., Mourtzos, M.-A., Kassimis, G., and Fragakis, N. (2024). Intravenous Landiolol for Rate Control in Supraventricular Tachyarrhythmias in Patients with Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061683"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1253\/circj.CJ-16-0281","article-title":"Lower Radiation Exposure Needs Lower Heart Rate","volume":"80","author":"Yamamoto","year":"2016","journal-title":"Circ. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13318-014-0244-3","article-title":"Evaluation of clinical bradycardiac effect and respiratory adverse effect of \u03b2-blocking agents in coronary computed tomography angiography based on theoretical analysis","volume":"41","author":"Fujito","year":"2016","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3111\/13696998.2013.877021","article-title":"Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan","volume":"17","author":"Igarashi","year":"2014","journal-title":"J. Med. Econ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1515\/ract-2018-2980","article-title":"Radioiodination and biological evaluation of landiolol as a tracer for myocardial perfusion imaging: Preclinical evaluation and diagnostic nuclear imaging","volume":"106","author":"Sanad","year":"2018","journal-title":"Radiochim. Acta"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5216\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:40Z","timestamp":1760033680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":43,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155216"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155216","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}